摘要:
The invention provides crystalline hydrochloride salts of (S) -3-[ (S) -2-methanesulfonyl-1-(4-trifluoromethylphenoxy)ethyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salts, processes and intermediates for preparing the crystalline salts, and methods of using the crystalline salts to treat diseases.
摘要:
The invention provides processes for preparing intermediates useful for preparing compounds of the formula (IV), or a salt thereof, where R 1-3 are as defined in the specification.
摘要:
The invention provides a crystalline sulfate salt of 3-endo-(8-{2-[cyclohexylmethyl-((S)-2,3-dihydroxy-propionyl)amino]ethyl}-8-aza-bicyclo[3.2.1]oct-3-yl)benzamide or a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salt forms, methods of using such crystalline salt forms to treat diseases associated with mu opioid receptor activity, and processes useful for preparing such crystalline salt forms.
摘要:
Among its several embodiments, the present invention provides an improved process for the preparation of tetrahydrobenzothiepine-1,1-dioxide compounds; the provision of a process for preparing a diastereomeric mixture of tetrahydrobenzothiepine-1,1-dioxide compounds from a single diastereomer of such compounds; the provision of a process for the preparation of 3-bromo-2-substituted propionaldehyde compounds; and the provision of a process for the preparation of 3-thio-2-substituted propionaldehyde compounds.
摘要:
This invention is directed generally to a process for making α-substituted hydroxamic acids (including salts thereof) generally corresponding in structure to formula (I) wherein n, Z, Z 3 , A, R, E, and Y are as defined in this patent. This invention also is directed to compounds that may, for example, be used as intermediates in such a process, as well as processes for making such compounds.
摘要:
The invention herein is directed to a process for the preparation of ethyl 3S-amino-4-pentynoate which involves treating 3-(trimethylsilyl)-2-propynal with L-phenylglycinol in toluen to produce alpha S-[[3-(trimethylsilyl)-2-propynyliden]amino]benzenethanol; reacting alpha S-[[3-(trimethylsilyl)-2-propynylidene]amino]benzenethanol with BrZnCH>2 2
摘要:
The invention provides an efficient method for preparing 3-endo-(S- azabicyclo[3.2.1]oct-3-yl)benzamide by hydrogenation, under controlled conditions, of an amino-protected 3-(8-azabicyclo[3.2.1]oct-2-en-3-yl)benzamide intermediate in which the amino-protecting group is removable by catalytic hydrogenation.
摘要:
This invention relates to compounds of formula (I) Wherein R 1 and R 2 are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions and combinations comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compound to for example, treat pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.
摘要:
The invention herein is directed to a process for the preparation of chiral beta -amino acids and esters of formula (I), wherein X and Y are the same or different halo groups, R is H or lower alkyl and isomers and pharmaceutically acceptable salts thereof.
摘要:
The invention provides a process of preparing an intermediate useful in the synthesis of biphenyl-2-ylcarbamic acid l-(2-{[4-(4-carbamoylpiperidin-l-ylmethyl) benzoyl]methylamino}ethyl)piperidin-4-yl ester, and a process of preparing a crystalline freebase of the ester.